News
Cost-effectiveness of adjuvant therapy for treatment of stage II colon cancer in patients with diabetes. Background: The MAPK pathway is a crucial regulator of cell proliferation, survival, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback